www.tyvaso.com Open in urlscan Pro
45.60.45.59  Public Scan

Submitted URL: https://tyvasonebulizerdelivers.com/
Effective URL: https://www.tyvaso.com/pah/about-tyvaso/tyvaso-dpi/
Submission: On November 14 via api from BE — Scanned from US

Form analysis 0 forms found in the DOM

Text Content

TYVASO DPI IS NOW APPROVED

Skip to main content
 * Important Safety Information
 * Prescribing Information
    * TYVASO
    * TYVASO DPI

 * Instructions for Use
    * TYVASO
    * TYVASO DPI

 * The information contained in this section of the site is clinical in nature
   and specifically created for healthcare professionals. If you are not a US
   healthcare professional, please click CLOSE to return to the consumer section
   of the site.
   
   Close
   
   Yes, I am a US healthcare professional and would like to continue.
   
   Continue
   
   For US Healthcare Professionals

SELECT A CONDITION

 * PH-ILD (WHO GROUP 3)
 * PAH (WHO GROUP 1)


PATIENT SUPPORT PROGRAM
 * UNDERSTANDING PAH
   * OUR STORY
 * ABOUT TYVASO
   * TYVASO DPI
   * TYVASO NEBULIZER
   * CLINICAL FINDINGS
 * STARTING TYVASO
   * HOW TO TAKE TYVASO
   * SIDE EFFECTS
   * ACCESS AND PATIENT SUPPORT
   * COST ASSISTANCE
 * TYVASO RESOURCES
   * FAQs
   * GLOSSARY
   * DOWNLOADABLE RESOURCES
   * VIDEOS

Mobile Menu Button

UNDERSTANDING PAH

 * OUR STORY

ABOUT TYVASO

 * TYVASO DPI
 * TYVASO NEBULIZER
 * CLINICAL FINDINGS

STARTING TYVASO

 * HOW TO TAKE TYVASO
 * SIDE EFFECTS
 * ACCESS AND PATIENT SUPPORT
 * COST ASSISTANCE

TYVASO RESOURCES

 * FAQs
 * GLOSSARY
 * DOWNLOADABLE RESOURCES
 * VIDEOS

 * Important Safety Information

 * Prescribing Information
    * TYVASO
    * TYVASO DPI

 * Instructions for Use
    * TYVASO
    * TYVASO DPI

 * The information contained in this section of the site is clinical in nature
   and specifically created for healthcare professionals. If you are not a US
   healthcare professional, please click CLOSE to return to the consumer section
   of the site.
   
   Close
   
   Yes, I am a US healthcare professional and would like to continue.
   
   Continue
   
   For US Healthcare Professionals

SELECT A CONDITION

 * PH-ILD (WHO GROUP 3)
 * PAH (WHO GROUP 1)


PATIENT SUPPORT PROGRAM


TYVASO DPI


FITS IN THE PALM OF YOUR HAND

This small, portable inhaler uses cartridges and features a simple-to-use
design.

 * Conveniently portable
 * Single-dose cartridges prefilled with medicine
 * Just 1 breath per cartridge, 4x daily




TAKING A DOSE IS AS SIMPLE AS:
JUST ONE BREATH—
OPEN, LOAD, INHALE

98% patient satisfaction rate with TYVASO DPI

TYVASO DPI received high satisfaction marks from 45 of 46 people in a clinical
study who switched from the TYVASO nebulizer.*

*In the clinical study, 51 people with PAH who had been using the TYVASO
nebulizer for at least 3 months switched to TYVASO DPI. Researchers recorded
side effects, and after 3 weeks, 46 patients rated their satisfaction with
TYVASO DPI in a questionnaire.

Download information to discuss with your doctor


WATCH HOW SIMPLE IT
IS TO USE TYVASO DPI




IMPORTANT SAFETY
INFORMATION


BEFORE YOU TAKE TYVASO OR TYVASO DPI, TELL YOUR HEALTHCARE PROVIDER ABOUT ALL OF
YOUR MEDICAL CONDITIONS, INCLUDING IF YOU:

 * Have low blood pressure
 * Have or have had bleeding problems

EXPAND




IMPORTANT SAFETY
INFORMATION

COLLAPSE



BEFORE YOU TAKE TYVASO OR TYVASO DPI, TELL YOUR HEALTHCARE PROVIDER ABOUT ALL OF
YOUR MEDICAL CONDITIONS, INCLUDING IF YOU:

 * Have low blood pressure
 * Have or have had bleeding problems
 * Have asthma or chronic obstructive pulmonary disease (COPD)
 * Are pregnant or plan to become pregnant. It is not known if either product
   will harm your unborn baby.
 * Are breastfeeding or plan to breastfeed. It is not known if either product
   passes into your breast milk. Talk to your healthcare provider about the best
   way to feed your baby during treatment.


TELL YOUR HEALTHCARE PROVIDER ABOUT ALL OF THE MEDICINES YOU TAKE, INCLUDING
PRESCRIPTION AND OVER-THE-COUNTER MEDICINES, VITAMINS, AND HERBAL SUPPLEMENTS.
EITHER PRODUCT AND OTHER MEDICINES MAY AFFECT EACH OTHER.


ESPECIALLY TELL YOUR HEALTHCARE PROVIDER IF YOU TAKE:

 * Medicines used to treat high blood pressure or heart disease
 * Medicines that decrease blood clotting (anticoagulants)
 * Water pills (diuretics)
 * Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)


WHAT ARE THE POSSIBLE SIDE EFFECTS OF TYVASO OR TYVASO DPI?

Both products can cause serious side effects, including:

 * Low blood pressure (symptomatic hypotension). If you have low blood pressure,
   either product may lower your blood pressure more.
 * Bleeding problems. Either product may increase the risk of bleeding,
   especially in people who take blood thinners (anticoagulants).

The most common side effects of both products are cough, headache, throat
irritation and pain, nausea, reddening of the face and neck (flushing), fainting
or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like
other inhaled prostaglandins, you may have trouble breathing after taking TYVASO
or TYVASO DPI because it may cause the muscles around your airway to tighten
(bronchospasm). These are not all the possible side effects. Call your doctor
for medical advice about side effects or if you have trouble breathing.

You may report side effects to the FDA at 


YOU ARE NOW LEAVING THE TYVASO.COM WEBSITE

This link will take you to a site maintained by a third party who is solely
responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return
to www.TYVASO.com.

CLOSE
CONTINUE

www.fda.gov/MedWatch

or call 1-800-FDA-1088.




WHAT ARE TYVASO AND TYVASO DPI?

TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil)
Inhalation Powder are prescription medicines used in adults to treat:

 * Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood
   pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the
   ability to exercise. Your ability to exercise decreases 4 hours after taking
   TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and
   effective in children under 18 years of age.
 * Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO
   Group 3), which is high blood pressure in the lungs due to inflammation and
   sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability
   to exercise.

The risk information provided here is not comprehensive. To learn more about
TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full
Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals
for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI™ Inhalation
Powder, and additional information at www.TYVASO.com or call 1-877-UNITHER
(1-877-864-8437).


TYVISIconMAY2022

DPI=dry powder inhaler; PAH=pulmonary arterial hypertension.

This site is intended for use by US residents only.

Drug Discard Program Privacy Policy Terms of Use Contact Us Site Map

This site is intended for use by US residents only.

TYVASO and TYVASO DPI are registered trademarks of United Therapeutics
Corporation.

All other brands are trademarks of their respective owners. The makers of these
brands are not affiliated with and do not endorse United Therapeutics or its
products.

© 2023 United Therapeutics Corporation. All rights reserved. US/TYV/0798